title: Commercialisation of CAR T-cell therapies: business model spectrum.
authors.affiliation: Asklepian Consulting, International House, 24 Holborn Viaduct, London EC1A 2BN, United Kingdom. Electronic address: nmalik@asklepianconsulting.com.
authors.forename: Nafees N
authors.initials: NN
authors.lastname: Malik
authors.affiliation: Cell and Gene Therapy Catapult, 12th Floor Tower Wing, Guy's Hospital, Great Maze Pond, London SE1 9RT, United Kingdom.
authors.forename: Matthew B
authors.initials: MB
authors.lastname: Durdy
mesh_terms: D006801:Humans; D007167:Immunotherapy / Q000191:economics*; D018803:Models, Economic; D009369:Neoplasms / Q000276:immunology*; D011948:Receptors, Antigen, T-Cell / Q000276:immunology*
chemical_list: D011948:Receptors, Antigen, T-Cell